FDA approves Roche’s VENTANA ALK (D5F3) CDx Assay for use on the VENTANA BenchMark ULTRA system

Roche (SIX: RO, ROG; OTCQX:RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved the VENTANA ALK (D5F3) CDx Assay1 for use on the VENTANA BenchMark ULTRA automated slide stainer. The assay is a companion diagnostic to aid in the identification of ALK-positive lung cancer patients who are eligible for treatment with Pfizer’s FDA-approved therapy XALKORI®(crizotinib).Continue reading

Preventing Heart Disease Among Hispanic Diabetes Patients in Arizona, Focus of UA Research

 

Reducing cardiovascular disease and complications among Hispanic diabetes patients in Arizona is the focus of a new research project for Tomas Nuño, PhD, assistant professor of public health practice and translational research at the UA Mel and Enid Zuckerman College of Public Health – Phoenix and the Department of Emergency Medicine at the UA College of Medicine – TucsonContinue reading

Announcing the 2017 AZBio Trailblazers

The 2017 AZBio Trailblazer Honorees are: House Speaker JD Mesnard, Senator Nancy Barto, Senator Kimberly Yee, Senator Kate Brophy McGee, Representative Lela Alston, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, and  Representative Jay Lawrence.Continue reading

Nine Life Science Companies Make The Top 5 in the Fall 2017 Arizona Innovation Challenge Finals

The Arizona Commerce Authority has announced the 25 semifinalists in the Fall 2017 round of the Arizona Innovation Challenge.  The semifinalists include: Breezing Co. (Tempe), GT Medical Technologies (Gilbert), Life365 Inc. (Tempe), Merchant’s Garden AgroTech Inc. (Tucson), MicronView LLC (Tucson), NanoPin Technologies Inc. (Phoenix), Resonea (Scottsdale), SkinSafe Inc. (Scottsdale), and VB Cosmetics Inc. (Chandler).Continue reading